Ann Arbor life sciences firm expands into China
ANN ARBOR—Endra Life Sciences Inc. (NASDAQ: NDRA), a developer of ultrasound technologies, today announced it has received Institutional Review Board approval from China’s Shanghai General Hospital for the first clinical …